Exploring the Epidemiology, Pathogenicity, and Therapeutic Options of Staphylococcus spp.: 2nd Edition

Dear Colleagues,

Staphylococci are the main inhabitants of skin and mucosa of both animals and humans, in which these opportunistic Gram-positive bacteria can be responsible for a great variety of infections, including pyoderma, otitis, abscesses, mastitis, urinary tract infections, and wound infections. 

Over the last decade, both coagulase-positive Staphylococci (CoPS) and coagulase-negative Staphylococci (CoNS) have become critically opportunistic animal pathogens, frequently being the primary etiological agents of infections such as otitis and pyoderma in small animals. Furthermore, the potential zoonotic transmission of these pathogens should not be underestimated, with animals acting as reservoirs for humans.

The recent emergence and rapid dissemination of multidrug-resistant staphylococcal strains, particularly methicillin-resistant S. aureus and S. pseudintermedius, showing increasingly frequent resistance to the antibiotic agents licensed for use in small and farm animal practice, represent a relevant threat to animal and public health. In the last decade, the antibiotic resistance issue has become increasingly relevant, underlining the need of a continuous surveillance of both methicillin-resistant and methicillin-susceptible Staphylococci, as well as the development of new and alternative therapeutic options. 

This Special Issue aims at establishing a collection of papers exploring the occurrence of Staphylococcus spp. in small animals, livestock, wildlife, and humans, the pathogenic mechanisms involved in the onset of the infection, the mechanisms of antibiotic resistance, the diagnostic tools, and the new alternative treatment approaches to prevent and limit the dissemination of multidrug-resistant strains. 

We look forward to receiving research articles, review articles, and short communications on these topics that warrant further exploration.

Dr. Francesca Paola Nocera
Prof. Dr. Patrizia Nebbia
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Staphylococcus spp.
• transmission
• pathogenesis of infections
• antibiotic resistance
• methicillin resistance
• therapy
• zoonotic diseases
• One Health

• Exploring the Epidemiology, Pathogenicity, and Therapeutic Options of Staphylococcus spp. in Pathogens (12 articles)